CVS Inks $69B Takeover of Aetna

Overview


The CVS Health-Aetna transaction, which issubject to approval by CVS Health and Aetna shareholders, regulatory approvals and other customary closing conditions,is expected to close in the second half of next year. Barclays and Goldman Sachs are serving as financial advisers to CVS Health, and Centerview Partners also provided financial advice to the CVS Health Board of Directors. The company was advised on legal matters by Shearman & Sterling LLP, Dechert LLP and McDermott Will & Emery LLP.